Lataa...
Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic target
Epstein Barr virus (EBV)-associated lymphoproliferative diseases (LPDs) express all EBV latent antigens (type III latency) in immunodeficient patients and limited antigens (type I and II latencies) in immunocompetent patients. Post-transplantation lymphoproliferative disease (PTLD) is the prototype...
Tallennettuna:
| Julkaisussa: | Exp Mol Med |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4314579/ https://ncbi.nlm.nih.gov/pubmed/25613733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/emm.2014.102 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|